Healthecon

What Healthecon does

HealthEcon AG is a Basel, Switzerland-based healthcare consulting firm founded in 1981 that provides Health Technology Assessment (HTA), European market access, reimbursement, and health economics advisory services to the pharmaceutical industry. The firm has completed more than 1,100 projects for over 200 clients, including most of the global top 20 pharmaceutical companies as well as mid-size biotechs, European governments, associations, and sickness funds. Its core offerings are organized around Market Access Consulting, Reimbursement Consulting, and AMNOG Services (covering early consulting, dossier preparation, oral hearings, and price negotiation), supplemented by service modules for early regulatory-HTA dialogue, landscape and gap analyses, regulatory and market access strategy alignment, clinical trial design consulting, value-centred evidence generation (including cost-effectiveness, budget impact, cost-utility, and cost-benefit analyses), international market access plans, EU-level HTA support, and medical/payer expert engagement.

The firm operates as a pure B2B professional services practice on a project-based or retainer fee model, with services delivered primarily from its Basel headquarters and supplemented by temporary on-site deployments to clients' regional offices across Europe. Its core technology is methodological expertise in health economic evaluation and real-world data utilization rather than a software platform, with the HealthEcon® AG trademark registered as its principal intangible asset. The firm is privately held and operates as part of the Athagoras group, hosted on IGES infrastructure (healthecon.iges.com), suggesting an affiliation with a broader European healthcare research and consulting platform, though no parent-company financials or ownership details are disclosed. Headcount is 11–50 employees, leadership includes Managing Director Stephan Ruckdäschel, and there is no disclosed evidence of funding rounds, M&A activity, or AI/ML capability development.

Name

Healthecon

Legal name

HealthEcon AG

Website

https://healthecon.com

Company type

Private

Founded year

1981

Operating status

Operating

Headcount range

11–50 employees

Short description

HealthEcon AG is a Basel-based healthcare consulting firm providing Health Technology Assessment, European market access, and reimbursement strategy services to global pharmaceutical companies and mid-size biotechs, with 1,100+ projects completed since 1981.

Ownership category

akta.pro rank

Product category

Pharmaceutical Market Access Consulting

NAICS

Other Scientific and Technical Consulting Services (54169)

SIC

Services-Health Services (8000)

akta.pro primary industry

Medical Affairs, Scientific Communications & HEOR FSP (HLAGAOAG)

akta.pro secondary industry

Third-Party/Outsourced Quality & Responsible Person Services (EU QP/RP, US Agent) (HLAGAKAO)

Keywords

• Healthcare consulting
• Market access services
• Health technology assessment
• Reimbursement strategy
• Pharmaceutical consulting

Headquarters

HQ city

Basel

HQ country

Switzerland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Professional Consulting Services: Fee-for-service consulting engagements for pharmaceutical companies on market access, HTA, reimbursement strategy, and regulatory affairs. Services provided from Basel office with on-site client support as needed.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels1 record

Core offering

HealthEcon provides consulting services in Health Technology Assessment, European market access, and value/reimbursement strategy for pharmaceutical companies. Core service lines include Market Access Consulting, Reimbursement Consulting, and AMNOG Services (German procedure support), supplemented by specialized advisory on early regulatory dialogue, landscape and gap analyses, clinical trial design, value-centred evidence generation, international market access plans, and payer/medical expert engagement.

Product overview

HealthEcon is a consulting firm providing healthcare market access advisory services to the pharmaceutical industry. Rather than a unified software platform, HealthEcon offers an integrated suite of consulting service modules organized around European market access, Health Technology Assessment, and reimbursement strategy. The core offerings include Market Access Consulting, Reimbursement Consulting, and AMNOG Services, supplemented by specialized service modules covering early regulatory dialogue, landscape analysis, clinical trial design, evidence generation, international market access planning, and payer expert engagement. All services are delivered from the Basel, Switzerland office, with temporary on-site support at client locations when required.

Differentiator

Problem solved

Functional benefit

Products and services

• Market Access Consulting
• Reimbursement Consulting
• AMNOG Services
• International Market Access Plans
• HTA in Europe Services

Named customers4 records

Segments1 record

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• AthagorasparentOthersAthagoras is the parent organization of Healthecon, as indicated by the 'Part of Athagoras' branding on the website. IGES Group is referenced as the broader organizational structure.

Scale indicators3 records

Recent moves4 records

Expansion highlights3 records

Direct peers

• Wickenstones: European life sciences consultancy focused on market access, pricing, and health economics across multiple EU markets. Comparable to HealthEcon in regional breadth and HTA/market access service scope, particularly for mid-size biotech.
• Cytel (formerly Ingress-Health): Statistical and HEOR consulting firm with strong European HTA heritage (Ingress-Health). Directly comparable to HealthEcon on health economic modeling, early HTA advice, and EU-level market access support for pharma.
• Validare: European consulting firm specializing in AMNOG, G-BA processes, and German market access for pharma. Direct competitor to HealthEcon on the German reimbursement dossier and negotiation workflow that is HealthEcon's signature offering.
• RTI Health Solutions: Not-for-profit HEOR, epidemiology, and market access consulting firm working with pharma clients globally. Directly comparable to HealthEcon in HEOR methods (cost-effectiveness, budget impact, RWE) and HTA dossier support, with broader therapeutic reach.
• MArS Market Access & Pricing Strategy: European boutique consultancy focused on market access, pricing, and reimbursement for pharma and medtech. Closely comparable to HealthEcon in regional focus and boutique HTA/reimbursement advisory positioning.
• Charles River Associates (CRA) — Life Sciences Practice: Economic and strategy consulting firm with a Life Sciences practice providing HEOR, market access, and pricing expertise to pharma. Closely comparable to HealthEcon on health economic evaluation and reimbursement strategy, with deeper litigation/economics overlap.
• Evidera: Global HEOR, market access, and real world evidence consulting firm serving pharma and biotech. Directly comparable to HealthEcon as a specialist advisor on HTA submissions, economic modeling, and reimbursement strategy, though at much larger scale and broader geographic footprint.
• Putnam Associates: Strategy consulting firm focused on pharmaceutical market access, pricing, and commercial strategy. Comparable to HealthEcon in payer strategy, global value dossier development, and launch sequencing for pharma clients.

Broad incumbents

• IQVIA (Real World Evidence / Consulting): Global life sciences data, analytics, and consulting giant with substantial HEOR, RWE, and market access practices. Overlaps with HealthEcon on HTA evidence generation and global value dossier work, but as part of a much wider data-and-CRO portfolio.
• IGES Group: Parent-affiliated German research and consulting group providing HTA, health economics, and market access services. Comparable to HealthEcon in HEOR and HTA expertise, with broader infrastructure and public-sector policy footprint.

Market position

Strengths2 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Healthecon